Modelled DT Structure
Method: homology modeling
Template PDB: 7BP3_A
Identity: 32.189%
Minimized Score: -871.511 kcal/mol
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0109 | ||||
Gene Name | SLC16A5 | ||||
Protein Name | Monocarboxylate transporter 6 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 7BP3_A Identity: 32.189% Minimized Score: -871.511 kcal/mol Detail: Structure Info |
||||
Synonyms | Monocarboxylate transporter 5; MCT 5; MCT 6; Solute carrier family 16 member 5; SLC16A5; MCT5; MCT6 | ||||
DT Family | Major Facilitator Superfamily (MFS) | ||||
Monocarboxylate Transporter (MCT) Family | |||||
Tissue Specificity | Highly expressed in kidney. | ||||
Function | This Proton-linked monocarboxylate transporter catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate. | ||||
Disease(s) | Edema associated with congestive heart failure [ICD-11: BD10] | ||||
Hyperuricaemia [ICD-11: 5C55.Y] | |||||
Endogenous Substrate(s) | Monocarboxylates | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
(γ) Outward/inward-facing Conformation |
|||||
(δ) Xenobiotics-regulated Structural Variability |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 3 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Bumetanide
|
Approved | Drug Info | Edema associated with congestive heart failure | BD10 | [1] |
Nateglinide
|
Approved | Drug Info | Diabetes | 5A10-5A14 | [1] |
Probenecid
|
Approved | Drug Info | Hyperuricaemia | 5C55.Y | [1] |
References | |||||
1 | Quercetin, Morin, Luteolin, and Phloretin Are Dietary Flavonoid Inhibitors of Monocarboxylate Transporter 6. Mol Pharm. 2017 Sep 5;14(9):2930-2936. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.